GSK increases stake in its publicly-listed Consumer Healthcare subsidiary in India to 72.5 per cent
5 February 2013 | By GlaxoSmithKline
“We are very pleased with the outcome of this transaction..."
List view / Grid view
News
Gilead announces sustained virologic response rates from two Phase 3 studies of sofosbuvir for hepatitis C
4 February 2013 | By Gilead Sciences, Inc.
Topline results from two Phase 3 studies...
Once-daily Lyxumia® (lixisenatide) approved for treatment of type 2 diabetes in Europe
4 February 2013 | By Sanofi
Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist...
B&W Tek announces enhanced high resolution Raman system with smart spectrometer technology
4 February 2013 | By B&W Tek, Inc.
B&W Tek is proud to announce the i-Raman® Plus portable Raman spectrometer...
GlaxoSmithKline starts Phase III study to test combined BRAF/MEK inhibition in patients with BRAF positive melanoma following surgery
1 February 2013 | By GlaxoSmithKline
GSK announced the start of COMBI-AD...
Obinutuzumab (GA101) significantly improved progression-free survival in people with chronic lymphocytic leukemia (CLL)
31 January 2013 | By Roche
Positive results from stage 1 of CLL11...
BASF completes acquisition of Pronova BioPharma
31 January 2013 | By BASF
BASF has completed the acquisition of Pronova BioPharma ASA, Lysaker, Norway...
Novo Nordisk increased operating profit by 32% in 2012
31 January 2013 | By Novo Nordisk
Sales growth of 18% driven by Victoza®, NovoRapid® and Levemir®...
Catalent Applied Drug Delivery Institute launches 2nd annual Global Academic Competition for Life Sciences Leaders of Tomorrow
30 January 2013 | By Catalent Pharma Solutions
Aim to encourage students...
FDA allows Mycoplasma release testing of a biopharmaceutical product using MycoTOOL®
In November 2012, the US Food and Drug Administration accepted the use of the MycoTOOL® PCR Mycoplasma Detection Kit as a release method for a biopharmaceutical product manufactured by Roche Applied Science intended for distribution in the United States.
Genzyme and Isis announce FDA approval of KYNAMRO™ injection for the treatment of HoFH
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
FDA Advisory Committee recommends approval of olodaterol* for maintenance treatment of COPD
29 January 2013 | By Boehringer Ingelheim
Olodaterol may provide a new treatment option in patients with COPD...
TARGAXAN® 550 (Rifaximin-alpha 550 mg tablets) launched in the UK
28 January 2013 | By Burson-Marsteller
Norgine Pharmaceuticals Limited and Alfa Wassermann are pleased to announce the launch of TARGAXAN® 550 in the UK...
Genzyme’s LEMTRADA™ application for MS accepted for review by the FDA
28 January 2013 | By Sanofi
Genzyme also reports very encouraging early launch indicators for AUBAGIO® (teriflunomide) in U.S.
Auvi-Q™ is now available in the U.S.
28 January 2013 | By Sanofi
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions...
